Pharmacy in Heart and Lung Transplant: The Latest Studies in Journal Watch

Published 26 January 2026
  • Advanced Heart Failure & Transplantation
  • Advanced Lung Failure & Transplantation
  • Early Career
  • Journal Watch
  • News
  • Pharmacy
  • Publications & Journals

The first Journal Watch of 2026 explores topics in transplant pharmacy. Issue editor Colleen Hutchinson, PharmD, BCCP, gathers topics including:

  • The NUDT16 genotype, and if it predicts development of neutropenia in lung transplant recipients receiving valganciclovir for CMV
  • Daratumumab monotherapy: can it desensitize patients awaiting heart transplant?
  • Early mammalian target of rapamycin inhibitor (mTORi) initiation with reduced tacrolimus for renal sparing in heart transplant recipients

Download Issue

Issue Junior Editor: 
Colleen Hutchinson headshotColleen Hutchinson, PharmD, BCCP
Cleveland Clinic

Cleveland, OH USA

 

 

 

 


Contributors:

Xinqi Liu headshotXinqi Liu, PharmD, BCTXP


Thomas Jefferson University Hospital
Philadelphia, PA USA

 

Kevin Reininger headshotKevin Reininger, PharmD, BCTXP


Mayo Clinic
Phoeniz, AZ USA

 

Devi Surajbali headshotDevi Surajbali, PharmD


Tampa General Hospital
Tampa, FL USA

 

Journal Watch Senior Editor

Ross Thomson, BA, BMBCh, MRCP

ISHLT Journal Watch is a periodic publication presented by the ISHLT Early Career and Trainee Committee. Are you an early career professional and looking to contribute to an upcoming issue of Journal Watch? Send an email to communications@ishlt.org for more information on how to participate.

Download Issue